ArthroCare receives FDA clearance for its second generation device for vertebral void creation


ArthroCare, a developer of minimally invasive surgical products, announced that it has received FDA clearance to market its second-generation Parallax Contour-enhanced vertebral augmentation device used for void creation in a vertebral body followed by injection of bone cement during vertebroplasty or kyphoplasty.  

This new lower profile device makes it easier for surgeons to operate in tight spaces and to provide additional tactile and audible feedback to improve ease of use during the void creation process.


The Contour-enhanced utilises a curved, movable stylet to displace cancellous bone within vertebrae, creating a void. This void is then filled with bone cement to stabilise the fracture.